DotNetNuke DNN Hosting

Policy Support

Prescription Drugs


Created by OBRA 1990, the Medicaid Drug Rebate Program requires drug manufacturers to have rebate agreements with the Secretary of Health and Human Services for states to receive federal funding for outpatient drugs dispensed to Medicaid patients as part of their fee-for-service programs. At the time the law was enacted, Managed care organizations (MCOs) were excluded from access to the drug rebate program.  This led many states to “carve out” pharmacy benefits and run prescription drug plans through their Medicaid agency. Though this allowed states to access the drug rebates, it made it difficult for MCOs to monitor their patients’ use of prescription drugs and, in turn, hampered care coordination efforts.

ACAP Position and Legislative Action

The Drug Rebate Equalization Act (DRE), a bill to extend drug rebates to Medicaid contracted health plans, passed in 2010 as a part of the Patient Protection and Affordable Care Act, due in large part to ACAP’s policy and advocacy efforts.  This policy was supported by various organizations representing state governments, Medicaid providers, and health plans. (Read letter of support here.) ACAP is committed to working with the Centers for Medicare & Medicaid Services (CMS) to implement the DRE as quickly and efficiently as possible and to ensure plan’s capitation rates appropriately reflect changes in manufacturers’ drug rebate policies.  In addition, ACAP is continues to work with its member plans to understand and analyze the obstacles each state faces in the move to a “carve-in” system of pharmacy benefits.

ACAP Documents Relating to Prescription Drugs

3/7/16 ACAP Response to Senate Finance Committee on High-Cost Breakthrough DrugsDownload
10/27/15 ACAP Comments to HRSA on Proposed 340B Drug Pricing Program Omnibus GuidanceDownload
4/30/14 ACAP Letter to Cindy Mann on SovaldiDownload
4/24/14 Coalition Letter to House Leadership on Reduction of Psychotropic Medications in Foster Care YouthDownload
4/15/14 Coalition Letter to Senate Leadership on Reduction of Psychotropic Medications in Foster Care YouthDownload
3/21/14 State Policies Regarding Medicaid MCO Preferred Drug ListsDownload
8/21/12 Letter to the FDA on Generic SuboxoneDownload
7/10/11 ACAP Fact Sheet: Implementation of Drug Rebate EqualizationDownload
2/04/11 ACAP Letter to CMS on DRE ImplementationDownload
4/22/10 CMS State Medicaid Letter on DRE Implementation GuidanceDownload
4/01/10 Health Reform’s Medicaid Drug Rebate Program Now in EffectDownload
2/26/09 President Obama's Budget Expands Health Coverage for More Americans and Modernizes the Medicaid Drug RebateDownload
9/22/08 Analysis of Dual Eligible Pharmacy Costs Under Medicaid and Medicare Part DDownload
9/22/08 Analysis of Drug Rebate Equalization Act's Savings to the Medicaid ProgramDownload
10/24/07 Programmatic Assessment of Carve-In and Carve-Out Arrangements for Medicaid Prescription DrugsDownload
4/18/07 FAQs on Drug RebateDownload
6/11/07 S.1589Download
3/5/07 Drug Rebate One PagerDownload
5/29/03 Extending the Federal Drug Rebate Program to Medicaid MCOs: Analysis of ImpactsDownload
1/1/03 Comparison of Medicaid Pharmacy Costs and Usage between the Fee-for-Service and Capitated SettingDownload